Concepedia

Thomas Forbes

TF

Statistics

Publications

6

Citations

195

H-Index

6

Active since

2011

Affiliations

National Cancer Institute(Current)

Frederick National Laboratory for Cancer Research

Leidos (United States)

National Institute of Standards and Technology

Leidos Biomedical Research Inc. (United States)

Thomas Forbes is an author at National Cancer Institute specializing in molecular oncology, dna sequencing, and life sciences.

Publications per year

2011–2021

6

Publications

6

The Papaver Self-Incompatibility Pollen S-Determinant, PrpS, Functions in Arabidopsis thaliana

Barend H. J. de Graaf, Sabina Vatovec, Javier Andrés Juárez‐Díaz et al. · Current Biology · 2011 · 45 citations · Full text

, , +17

Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial

Chih-Jian Lih, David Sims, Robin Harrington et al. · Journal of Molecular Diagnostics · 2015 · 45 citations · Full text

, , +16

Multiplex isothermal helicase-dependent amplification assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Victoria Doseeva, Thomas Forbes, John S. Wolff et al. · Diagnostic Microbiology and Infectious Disease · 2011 · 37 citations

, , +16

Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays

David Sims, Robin Harrington, Eric C. Polley et al. · Journal of Molecular Diagnostics · 2016 · 28 citations · Full text

, , +14

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health

P. Mickey Williams, Thomas Forbes, Steven P. Lund et al. · JCO Precision Oncology · 2021 · 21 citations · Full text

, , +15

1–5 of 6